• Non ci sono risultati.

A. Shai H. I. Maibach Wound Healing and Ulcers of the Skin Diagnosis and Therapy – The Practical Approach

N/A
N/A
Protected

Academic year: 2022

Condividi "A. Shai H. I. Maibach Wound Healing and Ulcers of the Skin Diagnosis and Therapy – The Practical Approach"

Copied!
19
0
0

Testo completo

(1)

A. Shai H. I. Maibach

Wound Healing and Ulcers of the Skin Diagnosis and Therapy –

The Practical Approach

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite I

(2)

A. Shai

H. I. Maibach

Wound Healing and Ulcers

of the Skin

Diagnosis and Therapy – The Practical Approach

With 115 Figures and 25 Tables

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite III

(3)

Dr. Avi Shai

Department of Dermatology Soroka University Medical Center Faculty of Health Sciences

Ben-Gurion University of the Negev Beer-Sheva 84105

Israel

Professor Howard I. Maibach Department of Dermatology University of California

San Francisco School of Medicine Box 0989

San Francisco, CA 94143-0989 USA

Library of Congress Control Number: 2004104389 ISBN 3-540-21275-2 Springer Berlin Heidelberg New York

This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcast- ing, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this pub- lication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer. Violations are liable to prosecution under the German Copyright Law.

Springer is a part of Springer Science+Business Media springeronline.com

© Springer-Verlag Berlin Heidelberg 2005 Printed in Germany

The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant pro- tective laws and regulations and therefore free for general use.

Product liability: the publishers cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature.

Editor: Marion Philipp Desk Editor: Irmela Bohn

Production: ProEdit GmbH, 69126 Heidelberg, Germany Cover: Frido Steinen-Broo, EStudio Calamar, Spain Typesetting: K. Detzner, 67346 Speyer, Germany Printed on acid-free paper 21/3150 ML 5 4 3 2 1 0

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite IV

(4)

In recent years, the amount of knowledge surrounding the processes of wound heal- ing has significantly increased, resulting in a vast array of therapeutic options. The assortment of preparations currently available may become somewhat perplexing to physicians and medical personnel.

We have become aware of the difficulty involved in selecting the most appropri- ate therapy for a specific type of wound. Our main purpose in writing this book, therefore, is to present a step-by-step algorithmic approach to the treatment of chronic wounds.

The caring of wounds has always been the realm of the various branches of sur- gery. Dermatology, on the other hand, being the medical science that specializes in skin and cutaneous physiology, deals with the essential and fundamental aspects of wound healing. Due to its very nature, wound healing overlaps into the many disci- plines of medicine in general. Internists, diabetologists, and geriatricians are be- coming increasingly involved in the field of wound care. General practitioners and family physicians are frequently required to treat acute and chronic wounds.

In this book, we introduce the dermatologic perspective of wound healing which applies to the diagnosis of cutaneous ulcers, based on history, physical examination, biopsy, and laboratory tests. We also present a therapeutic approach to ulcers ac- cording to their appearance.

We believe that this guidebook will assist physicians in the treatment of chronic wounds, and that it will ultimately serve to reduce the immense suffering of those af- flicted.

Note to the Reader.Neither the authors nor the publishers are liable for any con- sequences arising from the use of information presented in this book. The readers are advised to check for up-dated information provided by the manufacturers, including dosage and safety regulations, for each of the products described in this book. Ultimate responsibility rests with the treating physician.

Some of the chapters include lists of commercial names of preparations used in the healing of chronic ulcers. This is by no means intended as a commercial recom- mendation. It is simply intended to provide the readers with a guide to the range of brand names in use for a certain biologic substance. We have done our best to pro- vide up-dated and accurate lists. However, this area is subject to frequent changes, and the readers are advised to gather information from other currently available sources.

Preface

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite V

(5)

Acknowledgements

The authors wish to thank the following for providing this book with illustrations and pictures: Dr. Emanuela Cagnano for Figs. 12.1 (modified by Inanit Ashtamker as Fig. 1.1), 2.2, 6.1, 6.3, and 6.6; Dr. Oren Lapid for Figs. 12.3 and 12.4; Dr. David Vigoda for Fig. 12.5; Dr. Tidhar Steiner and the Semmelweis Museum of the History of Med- icine for Figs. 3.5 and 3.6; Dr. Alex Zvulunov for Fig. 4.2; Dr. Kosta Mumcuoglu for Figs. 9.6–9.8; Professor Sima Halevy for Figs. 14.1–14.7; Audra J. Gera and Novartis for Figs. 2.6 and 3.9, from Dermatology: A Medical Artist’s Interpretation, copyright 1990 by Sandoz Pharma LTD; The Wellcome Library, London, for Figs. 3.1–3.4, 3.7, and 8.8; Taylor & Francis Publishing House for Fig. 8.6, reprinted from Jacobsson et al: A new principle for the cleansing of infected wounds. Scandinavian Journal of Plastic & Reconsructive Surgery, 10 : 65–72, 1976; Taylor & Francis Publishing House for Fig. 20.2, reproduced from Handbook of Cosmetic Skin Care, published by Mar- tin Dunitz, 2001. Figure 18.1 is reprinted from T.J. Ryan: Wound healing and current dermatologic dressings. Clinics in Dermatology 8 : 21–29, copyright 1990, with per- mission from Elsevier Science; Fig. 2.5 is reprinted from Germain et al: Human wound healing fibroblasts have greater contractile properties than dermal fibro- blasts. Journal of Surgical Research 57 : 268–273, copyright 1994, with permission from Elsevier Science; Fig. 18.2 is reprinted from Dermatologic Therapy in General Practice, by M. Sulzberger and J. Wolf, (p 116), published by The Year-Book Publish- ers, copyright 1943, with permission from Elsevier Science; Fig. 6.2 is reprinted from Falanga et al: The cutaneous manifestations of cholesterol crystal embolization, Archives of Dermatology 122 : 1194–1198, copyright 1986, with permission from the American Medical Association; Fig. 4.4 is reprinted from S.W. Graeca et al: A painful precursor for necrosis. Postgraduate Medicine 106 : 249–250, copyright 1999, with permission from Postgraduate Medicine (photographed by Scott Dornbaser).

Fig. 6.4 is reprinted from J. Lima-Maribona et al: Self-assessment examination. The American Academy of Dermatology Journal 29 : 803, 1993, with permission from Mosby-Year Book, Inc.; part of Fig. 2.1 is reprinted from CIBA Clinical Symposia on common bleeding disorders, vol 35, no 3, p 8, copyright 1983, with permission from Novartis; part of Fig. 2.1 is taken from Dermatology: A Medical Artist’s Interpreta- tion, copyright 1990 by Sandoz Pharma LTD.

Many thanks are due to the following for their assistance in the preparation of the text and for their valuable comments: Dr. Gary Zentner; Professor Ilana Harman- Bohem; Professor Pablo Yagupsky; Dr. Batya Davidovici; Dr. Marcelo H. Grunwald;

Dr. Dafna Hallel-Halevy; and Dr. Emmilia Hodak. Our particular thanks go to all the reviewers of the chapters in this book for their efforts and assistance (see below); to Professor Sima Halevy, for advancing the field of wound healing in Soroka Uni- versity Medical Center and for actively supporting the production of this book; to Mrs. Rina Ben-Zeev for her assistance in the preparation of the Appendix section of the book and for constructive collaboration at the Chronic Wound Clinic; to Dr.Alex

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite VII

(6)

Zvulunov and Mr. Naftali Oron for their most valuable ongoing advice stemming from sheer wisdom and clear reason. We would like to especially thank Miss Kristina Hawthorne for contributing her vast experience in the production of books, for her creative ideas, and for her indispensable support and assistance throughout the whole course of this project.

Acknowledgements VIII

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite VIII

(7)

Contents

1 Basic Definitions and Introduction . . . 1

1.1 Definitions . . . 1

1.2 Three Aspects of Treatment in Wounds and Ulcers . . . 2

1.2.1 Etiology . . . 2

1.2.2 Clinical Appearance of the Ulcer . . . 3

1.2.3 Adjuvant Therapy . . . 3

1.3 Ulcer Depth . . . 3

1.4 Comments on Current Treatments . . . 4

References . . . 4

2 Natural Course of Wound Repair Versus Impaired Healing in Chronic Skin Ulcers . . . 7

2.1 Overview . . . 7

2.2 Inflammation Phase . . . 8

2.2.1 Vasoconstriction and Hemostasis . . . 8

2.2.2 Vasodilatation and Increased Permeability . . . 9

2.2.3 Chemotactic Growth Factors and Phagocytosis . . . 9

2.3 Tissue Formation Phase . . . . 9

2.3.1 Angiogenesis and Granulation Tissue Formation . . . 9

2.3.2 Extracellular Matrix Formation . . . 10

2.3.3 Re-epithelialization . . . 11

2.3.4 Wound Contraction . . . 11

2.3.5 Role of Nitric Oxide in Wound Healing . . . 12

2.4 Tissue Remodeling Phase . . . 12

2.5 Types of Repair . . . 13

2.6 Chronic Ulcers and Protracted Inflammation . . . . 13

2.6.1 Increased Enzymatic Activity of Matrix Proteases . . . 13

2.6.2 Reduced Responsiveness to Growth Factors . . . 13

2.6.3 Cell Senescence . . . 14

2.7 Concluding Remarks . . . 15

References . . . 15

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite IX

(8)

Contents X

3 Milestones in the History of Wound Healing . . . 19

3.1 Overview . . . 19

3.2 The Ancient World . . . 19

3.2.1 Medicine in Mesopotamia . . . 20

3.2.2 Ancient Egypt . . . 20

3.3 Inflammation, Infection and the Attitude to Appearance of Purulent Discharge in the Past . . . 21

3.4 Renaissance Era . . . 22

3.5 Antiseptics, Identification of Bacteria and the Use of Antibiotics . . . 23

3.5.1 Ignatz Phillip Semmelweis . . . 23

3.5.2 Joseph Lister . . . 23

3.5.3 Other Researchers . . . 25

3.5.4 Antibiotics . . . 26

3.6 Investigation of Wound Healing Processes . . . 26

3.7 The Significance of a Moist Wound Environment . . . . 26

3.8 Keratinocyte Cultures and Advanced Skin Substitutes . . . 27

3.9 Recent Developments . . . 27

3.10 Future Directions in Wound Healing . . . 27

References . . . 28

4 Etiology and Mechanisms of Cutaneous Ulcer Formation . . . 31

4.1 Overview: Etiologies of Cutaneous Ulcers . . . 31

4.2 Mechanisms of Ulcer Formation . . . 31

4.3 Mechanisms of Formation of Specific Types of Cutaneous Ulcers . . . 36

4.3.1 Ulceration Following Injury/External Damage to the Skin . . . 36

4.3.2 Infections . . . 37

4.3.3 Vascular Disease . . . 41

4.3.4 Leukocytoclastic Vasculitis . . . 44

4.3.5 Connective Tissue and Multisystem Diseases . . . 44

4.3.6 Hypercoagulable States . . . 44

4.3.7 Metabolic Disorders: Diabetes Mellitus . . . 45

4.3.8 Hematologic Abnormalities . . . 47

4.3.9 Nutritional Disorders . . . 48

4.3.10 Other Causes . . . 48

References . . . 48

5 Determining Etiology: History and Physical Examination . . . 53

5.1 Diagnostic Approach: Overview . . . 53

5.2 Incidence by Age: Common Causes of Ulcers in Adults and Children 54 5.2.1 Adults . . . 54

5.2.2 Children . . . 54

5.3 Typical Location of Various Cutaneous Ulcers . . . 56

5.3.1 Lower Legs . . . 56

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite X

(9)

Contents XI

5.3.2 Fingers and Toes . . . 59

5.3.3 Soles . . . 59

5.3.4 Facial Ulcers . . . 59

5.3.5 Genital Ulcers . . . 60

5.4 The Ulcer’s Appearance and Its Surroundings . . . 61

5.4.1 The Ulcer’s Margin . . . 61

5.4.2 The Skin that Surrounds the Ulcer . . . 62

5.5 The Primary Lesion from Which the Ulcer Originates . . . . 63

5.5.1 Ulcers Originating from a Plaque or a Nodule . . . 63

5.5.2 Ulcers that May Originate from a Vesicle or a Pustule . . . 63

5.5.3 Erythematous Area that Gradually Darkens . . . 63

5.6 Infectious Ulcers in Various Geographical Areas . . . 64

5.7 Additional Points . . . 65

5.8 Addendum: Details Regarding Venous and Arterial Ulcers . . . 66

5.8.1 Venous Ulcers . . . 66

5.8.2 Arterial Ulcers . . . 67

References . . . 67

6 Determining Etiology: Biopsy and Laboratory Investigation . . . 71

6.1 Overview . . . 71

6.2 A Cutaneous Ulcer in Which the Clinical Diagnosis Is Not Established . . . . 72

6.2.1 Possibilities of Histologic Picture . . . 72

6.2.2 Intravascular Occlusion . . . 72

6.2.3 Vasculitis . . . 76

6.2.4 Other Histologic Patterns . . . 79

6.2.5 Insufficient Histologic Data . . . 80

6.3 A Non-Healing Ulcer . . . 80

6.3.1 The Various Histologic Patterns . . . 80

6.3.2 Histologic Characteristics of Venous Ulcers . . . 80

6.3.3 Histologic Characteristics of Ischemic Ulcers . . . 82

6.3.4 ‘Unexpected’ Histologic Findings in Certain Types of Cutaneous Ulcers . . . 82

6.4 Suspected Malignancy . . . 82

6.4.1 When Should Malignancy Be Suspected? . . . 82

6.4.2 Epithelioma as a Primary Lesion . . . 83

6.4.3 Epithelioma Developing in a Long-Standing Cutaneous Ulcer . . . 83

6.5 An Ulcerated Nodule or Plaque . . . . 84

6.5.1 Ulcers Developing Within a Nodule or a Plaque . . . 84

6.5.2 Granulomatous Histologic Pattern . . . 84

6.5.3 Seeking an Infectious Cause . . . 84

6.6 Pyoderma Gangrenosum . . . 85

References . . . 86

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite XI

(10)

Contents XII

7 Ulcer Measurement and Patient Assessment . . . 89

7.1 Introduction . . . 89

7.2 Ulcer/Wound Measurements . . . 90

7.2.1 Precise Anatomic Site . . . 90

7.2.2 Measurement of the Ulcer Area . . . 91

7.2.3 Assessment of Depth . . . 93

7.2.4 Undermining . . . 94

7.2.5 Measurement in Cases of Infection or Suspected Infection . . . 94

7.2.6 Appearance of the Ulcer Surface and Spectrophotometry . . . 95

7.3 Patient Assessment . . . . 95

7.3.1 General . . . 95

7.3.2 Nutritional Deficits . . . 96

7.3.3 Drugs . . . 96

7.3.4 Edema . . . 96

7.3.5 Other Factors to Be Considered . . . 98

7.4 Summary Tables . . . 100

References . . . 100

8 Dressing Materials . . . 103

8.1 Overview . . . 103

8.2 Traditional Dressings: Non-Resorbable Gauze/Sponge Dressings . . . 103

8.3 Development of Advanced Dressing Modalities . . . 104

8.4 Features of Dressings . . . 104

8.4.1 Transparency . . . 104

8.4.2 Adhesiveness . . . 105

8.4.3 Form of Dressing . . . 105

8.4.4 Absorptive Capacity . . . 105

8.4.5 Permeability/Occlusiveness . . . 105

8.4.6 Antimicrobial Effect . . . 106

8.5 Advanced Dressing Modalities . . . 106

8.5.1 Occlusive Dressings: Films, Hydrocolloids, Foams . . . 106

8.5.2 Hydrogels . . . 110

8.5.3 Hydrophilic/Absorptive Dressings . . . 111

8.6 Other Types of Dressings . . . 114

8.6.1 Dressings Combining Two of the Above Groups . . . 114

8.6.2 Interactive Dressings . . . 114

8.6.3 Dressings with Unique Features . . . 115

8.6.4 Biological Dressings . . . 115

8.7 Summary . . . 115

References . . . 116

9 Debridement . . . 119

9.1 Definition of Debridement . . . 119

9.2 Appearance of Necrotic Material on an Ulcer’s Surface . . . 119

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite XII

(11)

Contents XIII

9.3 Why Should Ulcers Be Debrided? . . . 120

9.4 Methods of Debridement . . . 121

9.4.1 Surgical Debridement . . . 122

9.4.2 Mechanical Debridement . . . 125

9.4.3 A Variant of Mechanical Debridement: Absorptive Debridement . . . . 126

9.4.4 Chemical Debridement . . . 127

9.4.5 Autolytic Debridement . . . 129

9.4.6 Maggot Therapy . . . 129

9.5 Disadvantages of and Contraindications to Debridement: Final Comments . . . 131

9.6 Summary . . . 131

References . . . 132

10 Antibiotics, Antiseptics, and Cutaneous Ulcers . . . 136

10.1 Overview: Detrimental Effects of Bacteria on Wound Healing . . . 136

10.2 Antibiotics and Antiseptics: Definitions and Properties . . . 136

10.3 Infected Ulcers, Clean Ulcers, and Non-Healing ‘Unclean’ Ulcers . . . . 137

10.3.1 Infected Ulcers . . . 137

10.3.2 Clean Ulcers . . . 138

10.3.3 The Broad Spectrum Between Clean Ulcers and Infected Ulcers . . . 138

10.3.4 Non-Healing ‘Unclean’ Ulcers . . . 139

10.4 Systemic Antibiotics for Cutaneous Ulcers . . . 139

10.4.1 General . . . 139

10.4.2 Clinical Studies . . . 140

10.4.3 Arguments Against the Use of Systemic Antibiotics for Non-Healing ‘Unclean’ Cutaneous Ulcers . . . 140

10.4.4 Arguments Supporting the Use of Systemic Antibiotics for Non-Healing ‘Unclean’ Cutaneous Ulcers . . . 141

10.5 Topical Preparations for Infected Cutaneous Ulcers and ‘Unclean’ Ulcers . . . 141

10.5.1 Topical Antibiotics . . . 142

10.5.2 Topical Antiseptics . . . 142

10.5.3 Allergic Reactions to Topical Antibiotics and Antiseptics . . . 143

10.5.4 When to Consider the Use of Antiseptics or Topical Antibiotic Preparations . . . 143

10.6 Guidelines for the Use of Topical Antibiotics and Antiseptic Preparations in the Management of Cutaneous Ulcers 144 10.6.1 Avoid Toxic Antiseptics . . . 144

10.6.2 Base Selection of Antibiotics on Clinical Grounds . . . 144

10.6.3 Consider Carefully the Type of Antibiotic Preparation . . . 144

10.6.4 Take a Careful History Regarding Allergic Reactions . . . 145

10.6.5 Avoid Spreading Infection . . . 145

10.6.6 Cleanse and Debride the Ulcer . . . 145

10.6.7 Final Comment . . . 145

10.7 Addendum A: Collection and Identification of Pathogenic Bacteria . 145 10.7.1 Swabbing . . . 145

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite XIII

(12)

Contents XIV

10.7.2 Deep-Tissue Biopsy . . . 146

10.7.3 Needle Aspiration . . . 146

10.7.4 Curettage . . . 146

10.7.5 Conclusion . . . 146

10.8 Addendum B: Biofilms . . . 147

References . . . 147

11 Topical Antibacterial Agents . . . 151

11.1 Overview . . . 151

11.2 Oxidizing Agents . . . 151

11.2.1 Hydrogen Peroxide . . . 151

11.2.2 Potassium Permanganate . . . 152

11.3 Iodines . . . 152

11.3.1 Povidone-Iodine . . . 152

11.3.2 Other Iodine Compounds . . . 153

11.4 Chlorines . . . 153

11.5 Silver . . . 154

11.5.1 General Comments . . . 154

11.5.2 Silver Sulfadiazine . . . 154

11.6 Other Antiseptics . . . 155

11.6.1 Antiseptic Dyes . . . 155

11.6.2 Burow’s Solution . . . 156

11.7 Conclusion . . . 156

References . . . 156

12 Skin Grafting . . . 159

12.1 Introduction . . . 159

12.2 Split-Thickness Skin Graft and Full-Thickness Skin Graft . . . 160

12.3 Preparing a Cutaneous Ulcer for Grafting . . . 160

12.4 Forms of Autologous Grafting . . . 161

12.5 Conclusion . . . 162

References . . . 163

13 Skin Substitutes and Tissue-Engineered Skin Equivalents . . . 165

13.1 Overview . . . 165

13.2 ‘Non-Living’ Skin Substitutes . . . 165

13.2.1 General Functions . . . 165

13.2.2 Allogeneic Cadaver Skin . . . 165

13.2.3 Xenografts . . . 166

13.2.4 Naturally Occurring Collagen Matrix and Collagen-Containing Dressings . . . 166

13.2.5 Conclusion . . . 168

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite XIV

(13)

Contents XV

13.3 ‘Living’ Skin Substitutes . . . 168

13.3.1 General . . . 168

13.3.2 Epidermal: Keratinocyte Grafts . . . 169

13.3.3 Dermal Grafting . . . 172

13.3.4 Composite Grafts . . . 172

13.4 Summary . . . 173

References . . . 174

14 Human Skin Equivalents: When and How to Use . . . 177

14.1 General Structure and Mechanism of Action . . . 177

14.2 Product Description . . . 178

14.2.1 Apligraf . . . 178

14.2.2 OrCel . . . 178

14.3 Indications . . . 178

14.4 Instructions for Use . . . 179

14.4.1 Preparing the Ulcer Bed . . . 179

14.4.2 Steps to Take Prior to Applying the Product to the Ulcer Bed . . . 179

14.4.3 Grafting Procedure . . . 180

14.4.4 Dressing the HSE Layer . . . 180

14.4.5 Following Grafting . . . 180

14.5 Contraindications . . . 181

14.6 Efficacy . . . 181

14.7 Concluding Remark . . . 181

References . . . 183

15 Growth Factors . . . 185

15.1 Overview . . . 185

15.2 What Are Growth Factors? . . . 185

15.3 Beneficial Effects of Growth Factors on Acute Wounds and Chronic Cutaneous Ulcers . . . 186

15.4 Recombinant Human Platelet-Derived Growth Factor: rhPDGF (Becaplermin) . . . 186

15.5 Research Studies Using Recombinant Human PDGF . . . 187

15.6 PDGF: Indications and Contraindications . . . 187

15.7 Mode of Using PDGF Gel Preparation . . . 188

15.8 Topical Use of Other Growth Factors . . . 188

15.8.1 Granulocyte-Macrophage Colony-Stimulating Factor . . . 189

15.8.2 Epidermal Growth Factor . . . 189

15.9 Anti-Infective Effects of Growth Factors . . . 190

15.10 Summary and Future Research . . . 190

References . . . 190

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite XV

(14)

Contents XVI

16 Drugs, Wound Healing and Cutaneous Ulcers . . . 193

16.1 Overview . . . 193

16.2 Ulceration at the Injection Site . . . 194

16.2.1 Injections for Therapeutic Purposes – Subcutaneous or Intramuscular . . . 194

16.2.2 Injection for Therapeutic Purposes – Extravasation . . . 196

16.2.3 Accidental Injections . . . 196

16.2.4 Drug Abuse . . . 196

16.2.5 Self-Inflicted Ulcers . . . 197

16.3 Direct Cutaneous Exposure . . . 198

16.4 Systemic Drugs that Directly Induce Ulceration . . . 198

16.4.1 Causing or Aggravating Certain Diseases . . . 198

16.4.2 Induction of Vasculitis . . . 199

16.4.3 Vasospasm . . . 199

16.4.4 Drugs Affecting Coagulability . . . 199

16.4.5 Drugs Causing Bullae . . . 200

16.4.6 Unidentified Mechanisms . . . 200

16.5 Interference with Normal Mechanisms of Wound Healing . . . 200

16.5.1 Glucocorticoids . . . 201

16.5.2 Non-Steroidal Anti-Inflammatory Drugs . . . 202

16.5.3 Anti-Neoplastic and Immunosuppressive Drugs . . . 202

16.5.4 Other Drugs that Interfere with Healing . . . 202

16.6 Drugs that Adversely Affect Skin Quality . . . 202

16.6.1 Leg Edema . . . 202

16.6.2 Skin Atrophy or Scleroderma-Like Reactions . . . 203

References . . . 203

17 Alternative Topical Preparations . . . 209

17.1 Overview . . . 209

17.2 Herbal and Traditional Home Remedies . . . 210

17.2.1 Aloe Vera . . . 211

17.2.2 Calendula . . . 211

17.2.3 Other Herbal Extracts . . . 211

17.2.4 Balsam of Peru . . . 212

17.2.5 Clay . . . 212

17.3 Honey . . . 212

17.3.1 General . . . 212

17.3.2 Mode of Action: Why Does Honey Have a Beneficial Effect? . . . 212

17.3.3 Research . . . 213

17.3.4 Mode of Use . . . 214

17.3.5 Summary . . . 214

17.4 Conclusion . . . 214

References . . . 214

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite XVI

(15)

Contents XVII

18 Additional Topical Preparations . . . 217

18.1 Overview . . . 217

18.2 Vitamins and Trace Elements . . . 217

18.2.1 Topical Vitamin A and Derivatives . . . 217

18.2.2 Topical Zinc . . . 218

18.3 Scarlet Red . . . 219

18.4 Hyaluronic Acid Derivatives . . . 220

18.5 Biafine® . . . 220

References . . . 221

19 Nutrition and Cutaneous Ulcers . . . 223

19.1 Overview . . . 223

19.2 Malnutrition . . . 223

19.2.1 Assessment of Nutritional Status . . . 224

19.2.2 Protein Depletion . . . 224

19.2.3 Supplementation of Amino Acids . . . 225

19.2.4 Caloric- and Lipid-Deficient States . . . 225

19.2.5 Practical Conclusions . . . 226

19.2.6 Maintaining Appropriate Hydration . . . 226

19.2.7 Specific Types of Ulcers Directly Associated with Malnutrition . . . 226

19.3 Vitamins . . . 226

19.3.1 Vitamin A . . . 228

19.3.2 Vitamin C . . . 230

19.3.3 Vitamin E . . . 231

19.4 Trace Elements . . . 231

19.4.1 Zinc . . . 231

19.4.2 Iron . . . 233

19.4.3 Other Vitamins and Trace Elements . . . 233

19.4.4 Vitamin and Trace Element Supplementation in Patients with Cutaneous Ulcers . . . 234

19.5 Summary . . . 234

References . . . 235

20 Therapeutic Approach to Cutaneous Ulcers According to Appearance . . . 241

20.1 Overview . . . 241

20.2 Secreting ‘Yellow’ Ulcers . . . 242

20.2.1 Ulcers with Profuse and/or Purulent Secretion . . . 242

20.2.2 Ulcers with Mild to Moderate Secretion . . . 242

20.2.3 Additional Comments . . . 244

20.3 Dry ‘Black’ Ulcers . . . 244

20.4 ‘Sloughy’ Ulcers . . . 245

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite XVII

(16)

Contents XVIII

20.5 Clean ‘Red’ Ulcers . . . 247

20.5.1 Ulcers Advancing Towards Healing . . . 248

20.5.2 ‘Stagnant’ Ulcer . . . 248

20.6 ‘Unresponsive’ Ulcers . . . 249

20.7 ‘Mixed’ Ulcers . . . 250

20.8 Additional Comments . . . 250

20.9 Treating Hypergranulation Tissue . . . 250

20.10 Addendum: Dressings that Apply Topical Negative Pressure . . . 251

References . . . 252

21 Appendix: Guidelines for Patients and Medical Staff . . . 255

21.1 General Patient Guidelines for Treatment of Ulcers or Wounds at Home . . . 255

21.2 Patient Guidelines for the Management of Skin Ulcers Caused by Venous Insufficiency . . . 256

21.3 Patient Guidelines for the Management of Skin Ulcers Caused by Diabetes or Peripheral Arterial Disease . . . 256

21.4 Treatment of Edema . . . 257

References . . . 257

21.5 Guidelines for Nurses: Outpatient Management of Cutaneous Ulcers 258 References . . . 259

Subject Index . . . 261

List of Products . . . 269

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite XVIII

(17)

List of Reviewers

Natural Course of Wound Repair versus Impaired Healing in Chronic Cutaneous Ulcers

Theodora Mauro, MD

Associate Professor in Residence and Vice-Chairman Department of Dermatology

University of California, San Francisco Service Chief, Dermatology

San Francisco Veteran’s Hospital San Francisco, California USA

Milestones in the History of Wound Healing David T. Rovee, PhD

Cambridge, MA USA

Etiology and Mechanisms of Cutaneous Ulcer Formation Jürg Hafner, MD, PD

Dermatology, Vascular Medicine, Phlebology, Dermatologic Surgery Senior Staff Member

Department of Dermatology University Hospital of Zürich Zürich

Switzerland

Determining Etiology: History and Physical Examination Irwin M. Braverman, MD

Professor of Dermatology Department of Dermatology Yale Medical School

New Haven, CT USA

Determining Etiology: Biopsy and Laboratory Investigation Robert S. Kirsner, MD

Department of Dermatology and Cutaneous Surgery Department of Epidemiology and Public Health University of Miami School of Medicine Veterans Administration Medical Center Miami, Florida

USA

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite XIX

(18)

List of Reviewers XX

Ulcer Measurement and Patient Assessment Marco Romanelli, MD, PhD

Consultant Dermatologist Department of Dermatology University of Pisa

Pisa Italy

Dressing Materials Marketa Limova, MD Associate Clinical Professor Wound and Ulcer Clinic

University of California, San Francisco San Francisco, CA

USA

Debridement

William H. Eaglstein, MD Harvey Blank Professor

Department of Dermatology and Cutaneous Surgery University of Miami School of Medicine

Miami, FL USA

Antibiotics, Antiseptics and Cutaneous Ulcers Keith G. Harding, MD MB ChB MRCGP FRCS

Professor of Rehabilitation Medicine (Wound Healing) Head of Department of Surgery

Wound Healing Research Unit

University of Wales College of Medicine Cardiff

UK

Topical Antibacterial Agents Raza Aly, PhD

Professor of Dermatology and Microbiology Department of Dermatology

University of California San Francisco, CA USA

Skin Grafting I. Kelman Cohen, MD Emeritus Professor

Plastic and Reconstructive Surgery Virginia Commonwealth University Health Science Center

Richmond, Virginia USA

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite XX

(19)

List of Reviewers XXI

Skin Substitutes and Tissue-Engineered Skin Equivalents Tania J. Phillips, MD FRCPC

Professor of Dermatology

Boston University School of Medicine Department of Dermatology

Boston, MA USA

Growth Factors Martin C. Robson, MD Emeritus Professor of Surgery Department of Surgery

University of South Florida, Tampa Florida

USA

Drugs, Wound Healing and Cutaneous Ulcers Sima Halevy, MD

Professor of Dermatology Ben-Gurion University

Chairman, Department of Dermatology Soroka University Medical Center Beer Sheva

Israel

Nutrition and Cutaneous Ulcers Nancy Collins, PhD, RD, LD/N Nutrition Guidance Center Pembroke Pines

Florida USA

00_001_022_Titelei*** 01.09.2004 13:46 Uhr Seite XXI

Riferimenti

Documenti correlati

The chosen substances were: alcohol, caffeine, cannabis, hallucinogens (without separate categories for phencyclidine nor for arylcyclohexylamines and other hallucinogens),

To analize and evaluate health-risk behaviors among boys and girls in Pakistan.To compare health behaviours of adolescents in Pakistan and Lithuania.. Health Behavior in

When comparing to placebo, heart rate and blood lactate when taking the combination of supplements, was similar to that of caffeine alone which shows that probably there

in brain mass; exposure to both doses of Al resulted in statistically significant decrease of mice body weight. 2) Exposure to both doses of Aldid not change

Assuming a uniform density inside the nucleus, and referring to El-Maarry et al.(2015a)[7] for the definitions of the regions, five of these areas can reproduce the

We studied the formation of stars from colliding molecular clouds by per- forming smoothed particle hydrodynamic (SPH) simulations of six head-on collisions between two molecular

16 who investigated whether patient's age has influence on pain response after receiving palliative radiotherapy for bone metastases found that patients receiving multiple

After comparison of these two groups of respondents with different working hours with chemicals relative risk says that there is risk of all 4 respiratory related